Despite the fact that there are no data reporting that Graves' patients who have eye changes are at higher risk of thyroid cancers, we could speculate that, in the latter group of patients, NAMPT/visfatin/PBEF could be also partially responsible for worse prognosis of thyroid cancers. Here, NAMPT is linked to thyroid cancer.